CRISPR-Cas9 gene editing of inhibitory receptor signaling pathways improves CAR T cell activity against glioblastoma

被引：0
|
作者：
Sanber, Khaled [1 ]
Nawas, Zeid [1 ]
Salsman, Vita [1 ]
Gad, Ahmed [1 ]
Matthew, Pretty Rose [1 ]
Landi, Daniel [1 ]
Lee, Ciaran [2 ]
Sengal, Amel [1 ]
Chakraborty, Rikhia [1 ]
Joseph, Sujith [1 ]
Nabil, Ahmed [1 ]
Hegde, Meenakshi [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Rice Univ, Houston, TX USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2173
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2173
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Transgenerational CRISPR-Cas9 Activity Facilitates Multiplex Gene Editing in Allopolyploid Wheat
    Wang, Wei
    Pan, Qianli
    He, Fei
    Akhunova, Alina
    Chao, Shiaoman
    Trick, Harold
    Akhunov, Eduard
    CRISPR JOURNAL, 2018, 1 (01): : 65 - 74
  • [32] Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing
    Liras, Spiros (spiros.liras@pfizer.com), 2018, American Chemical Society (140)
  • [33] Megatal, Crispr/Cas9, and Talen T-Cell Receptor Gene Editing
    Osborn, Mark J.
    Webber, Beau R.
    Knipping, Friederike
    Lonetree, Cara-lin
    DeFeo, Anthony
    McElroy, Amber
    Starker, Colby
    Gabriel, Richard
    Merkel, Sarah
    Hippen, Keli L.
    Voytas, Daniel
    von Kalle, Christof
    Schmidt, Manfred
    Miller, Jeffrey S.
    Jarjour, Jordan
    Astrakhan, Alexander
    Scharenberg, Andrew M.
    Tolar, Jakub
    Blazar, Bruce R.
    BLOOD, 2015, 126 (23)
  • [34] Approval of the First CRISPR-Cas9 Gene Editing Therapy for Sickle Cell Disease
    Campbell, Sean T.
    CLINICAL CHEMISTRY, 2024, 70 (10) : 1298 - 1298
  • [35] Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing
    Rouet, Romain
    Thuma, Benjamin A.
    Roy, Marc D.
    Lintner, Nathanael G.
    Rubitski, David M.
    Finley, James E.
    Wisniewska, Hanna M.
    Mendonsa, Rima
    Hirsh, Ariana
    de Onate, Lorena
    Barron, Joan Compte
    McLellan, Thomas J.
    Bellenger, Justin
    Feng, Xidong
    Varghese, Alison
    Chrunyk, Boris A.
    Borzilleri, Kris
    Hesp, Kevin D.
    Zhou, Kaihong
    Ma, Nannan
    Tu, Meihua
    Dullea, Robert
    McClure, Kim F.
    Wilson, Ross C.
    Liras, Spiros
    Mascitti, Vincent
    Doudna, Jennifer A.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (21) : 6596 - 6603
  • [36] Gene Editing in Trypanosomatids: Tips and Tricks in the CRISPR-Cas9 Era
    Yagoubat, Akila
    Corrales, Rosa M.
    Bastien, Patrick
    Leveque, Maude F.
    Sterkers, Yvon
    TRENDS IN PARASITOLOGY, 2020, 36 (09) : 745 - 760
  • [37] Alzheimer disease mice improve with CRISPR-Cas9 gene editing
    Fyfe, Ian
    NATURE REVIEWS NEUROLOGY, 2019, 15 (05) : 247 - 247
  • [38] Gene Editing with Crispr-Cas9 for Treating Beta-Hemoglobinopathies
    Lee, Ciaran
    Bao, Gang
    Porteus, Matthew H.
    Cornu, Tatjana
    Miccio, Annarita
    Cradick, Thomas
    Cathomen, Toni
    Lundberg, Ante
    Mavilio, Fulvio
    BLOOD, 2015, 126 (23)
  • [39] Gene Editing and Crop Improvement Using CRISPR-Cas9 System
    Arora, Leena
    Narula, Alka
    FRONTIERS IN PLANT SCIENCE, 2017, 8
  • [40] Reversible RNA acylation for control of CRISPR-Cas9 gene editing
    Habibian, Maryam
    McKinlay, Colin
    Blake, Timothy R.
    Kietrys, Anna M.
    Waymouth, Robert M.
    Wender, Paul A.
    Kool, Eric T.
    CHEMICAL SCIENCE, 2020, 11 (04) : 1011 - 1016
12345